Inspection Readiness: Defending Your Use of AI to FDA and Auditors
Why take this course?
Artificial intelligence is increasingly embedded in quality system activities, yet its use is often informal, inconsistently applied, and not clearly reflected in procedures or documentation. During inspections, regulators do not evaluate tools directly; they assess how processes are executed, how outputs are verified, and whether accountability is clearly established. When AI influences activities such as SOP development, CAPA investigations, or training content without defined controls, gaps in traceability and inconsistent explanations quickly expose weaknesses in process control.
This session focuses on how organizations can prepare to defend AI use under inspection conditions by aligning it with established quality system expectations. It examines how inspections unfold in practice, where AI involvement becomes visible, and how inconsistencies between documentation and execution trigger deeper scrutiny. Emphasis is placed on defining controlled use, maintaining alignment between procedures and real-world execution, preparing personnel to respond consistently, and ensuring documentation provides clear evidence of how outputs were generated, reviewed, and justified.
Key Areas Covered
Charles H. Paul
Charles H. Paul has over 30 years of experience in regulatory consulting, training development, and documentation practices across FDA-regulated industries. His work in designing training systems and addressing complex documentation challenges directly supports the need to align AI-supported processes with controlled procedures and consistent execution under inspection conditions.
Ready to Strengthen Your Team? Let’s Build Your Training Plan.
Your team deserves the clarity.
Your organization deserves the confidence.
Upcoming Courses
Your TalkFDA Webinar Experience
1. Confirmation
3. Join the Live Training
4. Watch Again Anytime
Testimonials


